The duration and severity of COVID-19 are related to age, comorbidities, and cytokine
synthesis. This study evaluated the impact of these factors on patients with clinical …

There is considerable interest in the waning of effectiveness of coronavirus disease 2019
(COVID-19) vaccines and vaccine effectiveness (VE) of booster doses. Using linked national …

Coronavac is a widely used SARS-CoV-2 inactivated vaccine, but its long-term immune
response assessment is still lacking. We evaluated SARS-CoV-2-specific immune …

Objective To estimate the change in odds of covid-19 over time following primary series
completion of the inactivated whole virus vaccine CoronaVac (Sinovac Biotech) in São …

Objective. To characterize the epidemiological and clinical profile of individuals more likely
to become infected with SARS-CoV-2 after the fully vaccination schedule in order to profile …

While most approved vaccines are based on the viral spike protein or its immunogenic
regions, inactivated whole-virion vaccines (eg, CoronaVac) contain additional antigens that …

Much of the global population now has some level of adaptive immunity to SARS-CoV-2
induced by exposure to the virus (natural infection), vaccination, or a combination of both …

To investigate the clinical characteristic of domestic coronavirus disease 2019 (COVID-19)
patients after vaccination campaign conducted in China. According to vaccination status and …

Objectives This study aimed to evaluate the long-term antibody kinetics after vaccinating
with an inactivated COVID-19 Vero cell vaccine (CoronaVac) in healthcare workers (HCWs) …

Objectives: This study aims to evaluate the effectiveness of the inactivated SARS-COV-2
vaccine (Sinovac-CoronaVac), first administered to healthcare professionals in Turkey on …